Jazz Pharmaceuticals (JAZZ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 80 | 17.7% |
| Current Price ( 3/22 4:00PM EDT) | $138.46 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 3,659.4 | |||
| Sales Growth Forecast | 7.9% | |||
| Net Profit Margin | 34.1% | |||
| Projected Shares Outstanding | 70.06 | |||
| EPS - Five year Forecast | $26.06 | |||
| Average P/E Ratio | 12.0 | |||
| Projected Average Price | $312.76 | |||
| Price Appreciation (Annualized) | 17.7% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 17.7% | |||
| Quality | ||||
| Financial Strength | 98 | 24.5 | ||
| EPS Stability | 71 | 17.8 | ||
| Industry Sales Growth Rate | 15.0% | 6.6 | ||
| Industry Net Profit Margin | 30.0% | 14.2 | ||
| Calculated Quality Rating | 63.1 | |||
| Fool CAPS | ||||
Total Players
284
Outperforms
66
Underperforms
All-Stars (60)
44
Outperforms (73%)
16
Underperforms
|
||||
| Fundamental Data Updated: 03/03/2023 | ||||